Hyloris Pharmaceuticals Statistics

Total Valuation

EBR:HYL has a market cap or net worth of EUR 163.52 million. The enterprise value is 146.05 million.

Market Cap	163.52M
Enterprise Value	146.05M

Important Dates

The last earnings date was Thursday, September 25, 2025.

Earnings Date	Sep 25, 2025
Ex-Dividend Date	n/a

Share Statistics

EBR:HYL has 28.00 million shares outstanding. The number of shares has decreased by -4.61% in one year.

Current Share Class	28.00M
Shares Outstanding	28.00M
Shares Change (YoY)	-4.61%
Shares Change (QoQ)	+1.44%
Owned by Insiders (%)	56.83%
Owned by Institutions (%)	0.02%
Float	12.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.33
PB Ratio	5.66
P/TBV Ratio	6.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-22.78
EV / Sales	17.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.17

Financial Position

The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.06.

Current Ratio	3.82
Quick Ratio	3.76
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.24
Interest Coverage	-9.92

Financial Efficiency

Return on equity (ROE) is -20.18% and return on invested capital (ROIC) is -11.11%.

Return on Equity (ROE)	-20.18%
Return on Assets (ROA)	-9.03%
Return on Invested Capital (ROIC)	-11.11%
Return on Capital Employed (ROCE)	-19.40%
Revenue Per Employee	172,633
Profits Per Employee	-130,857
Employee Count	49
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	-162,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.39% in the last 52 weeks. The beta is 0.32, so EBR:HYL's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+1.39%
50-Day Moving Average	6.46
200-Day Moving Average	6.01
Relative Strength Index (RSI)	31.87
Average Volume (20 Days)	5,058

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EBR:HYL had revenue of EUR 8.46 million and -6.41 million in losses. Loss per share was -0.24.

Revenue	8.46M
Gross Profit	8.21M
Operating Income	-5.96M
Pretax Income	-6.57M
Net Income	-6.41M
EBITDA	-5.81M
EBIT	-5.96M
Loss Per Share	-0.24

Full Income Statement

Balance Sheet

The company has 19.12 million in cash and 1.65 million in debt, giving a net cash position of 17.47 million or 0.62 per share.

Cash & Cash Equivalents	19.12M
Total Debt	1.65M
Net Cash	17.47M
Net Cash Per Share	0.62
Equity (Book Value)	28.89M
Book Value Per Share	1.06
Working Capital	17.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.89 million and capital expenditures -7,000, giving a free cash flow of -6.90 million.

Operating Cash Flow	-6.89M
Capital Expenditures	-7,000
Free Cash Flow	-6.90M
FCF Per Share	-0.25

Full Cash Flow Statement

Margins

Gross margin is 97.08%, with operating and profit margins of -70.47% and -75.80%.

Gross Margin	97.08%
Operating Margin	-70.47%
Pretax Margin	-77.72%
Profit Margin	-75.80%
EBITDA Margin	-68.66%
EBIT Margin	-70.47%
FCF Margin	n/a

Dividends & Yields

EBR:HYL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.61%
Shareholder Yield	n/a
Earnings Yield	-3.92%
FCF Yield	-4.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EBR:HYL has an Altman Z-Score of 9.84 and a Piotroski F-Score of 2.

Altman Z-Score	9.84
Piotroski F-Score	2